Home » Topics » BioWorld Science

BioWorld Science
RSS

NIH grants supports Hepseros' development of human-on-a-chip technology

Sep. 7, 2018

Atara Biotherapeutics to develop CAR T immunotherapies with Moffitt Cancer Center

Sep. 7, 2018

Luye initiates phase III trials in China with LY-01005 for prostate cancer

Sep. 7, 2018

Eli Lilly presents AOC3 inhibitors

Sep. 7, 2018

Phase IIa study of Yeliva for cholangiocarcinoma advances to second stage

Sep. 7, 2018

FDA approves Tiglutik oral suspension for the treatment of ALS

Sep. 7, 2018

Chinese researchers disclose Abeta aggregation inhibitors

Sep. 7, 2018

Xenon Pharmaceuticals to develop ezogabine for KCNQ2 epileptic encephalopathy

Sep. 7, 2018

A*STAR identifies new SMYD3 inhibitors for cancer

Sep. 7, 2018

Torrent Pharmaceuticals patents compounds for asthma and COPD

Sep. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.